Stock Market

ROSEN, SENIOR DRIVER ADVISOR, Advises Investors of Kyverna Therapeutics, Inc. Defending Counsel Before a Critical Cut-off Date in a Securities Class Action.

New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: The Rosen Law Firm, a global investor rights law firm, is reminding buyers of Kyverna Therapeutics, Inc.’s common stock. (NASDAQ: KYTX) pursuant to and/or attributable to Kyverna’s initial public offering on February 8, 2024 (“IPO”). , in the essentials February 7, 2025 is the deadline for the plaintiff.

NOW: If you have purchased Kyverna common stock you may be entitled to compensation without payment of any out-of-pocket expenses or expenses through an emergency fund plan.

WHAT YOU NEED TO DO: To join a Kyverna class action, visit or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action. A class action lawsuit has already been filed. If you wish to act as the lead plaintiff, you must remove the Court no later than February 7, 2025. The lead plaintiff is the organization representing the other members of the class directing the lawsuit.

WHY THE LAW WENT OUT: We encourage investors to select qualified advisors with a track record of success in leadership roles. Generally, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these companies are not responsible for the actions of the security department, but they are partners who refer customers or partners with law firms who prosecute cases. Be wise in choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class actions and shareholder exit litigation. The Rosen Law Firm won the largest securities class action settlement ever against a Chinese Company at the time. The Rosen Law Firm is ranked #1 by ISS Securities Class Action (WA:) Value services for securities class agreements in 2017. The company has been listed in the top 4 every year since 2013 and has returned hundreds of millions of dollars to investors. In 2019 alone the company secured more than 438 million from investors. In 2020, founding partner Laurence Rosen was named by Law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.

CASE DETAILS: According to the lawsuit, the registration statement and prospectus used to conduct Kyverna’s IPO misstated and/or omitted facts about the results of Kyverna’s ongoing testing of KYV-101, Kyverna’s lead product candidate, in clinical trials. Specifically, Kyverna promoted patient “improvement” in certain indications while failing to disclose negative data about one of Kyverna’s trials, negative data that Kyverna was aware of at the time of the IPO. When true information enters the market, the lawsuit claims that investors suffered damages.

To join a Kyverna class action, visit or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about the class action.

No Class Guaranteed. Until the class is certified, you are not represented by an attorney unless you retain it. You can choose the advice of your choice. You can also remain a member of the absent class and do nothing for now. The investor’s ability to participate in any potential future returns is not dependent on performance as the lead claimant.

Follow us for updates on LinkedIn: on Twitter: or on Facebook (NASDAQ:):

Advocate advertising. Previous results do not guarantee the same result.

——————————

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235359




Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button